Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

1 ArticlesAARTIDRUGS

1 / 1

Portfolio: Exiting Aarti Drugs and GSFC From Momentum

Markets have been seeing red continuously. Nifty is down by 2.6% in last five trading sessions. We got rid of two positions from momentum portfolio as they ...

Nov 04, 2016

SquareAd.png

Join Capitalmind Premium

Starts at ₹1,499/mo

Get access to our equity, fixed income, macro and personal finance research, model equity and fixed-income portfolios, exclusive apps, tutorials, and member community.